1-11 of 11
William Brian Dalton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PSAT1 Suppression Drives a Targetable Serine Dependence in AML

Ilias Sinanidis, Panagiotis Tsakiroglou, Rebecca Foertsch, Julia Gondek, Benjamin Dubner, InYoung Choi, Bogdan Paun, Liang Zhao, Everett Stone, George Georgiou, Gabriel Ghiaur, William Brian Dalton
Journal: Blood
Blood (2024) 144 (Supplement 1): 1383.
https://doi.org/10.1182/blood-2024-211885
Published: 2024
Journal Articles

Efficacy and Tolerability of Blinatumomab in Clinical Trial Ineligible Patients with CD19+ Leukemias

John Preston Claiborne, Daniel Li, B. Douglas Smith, Mark J. Levis, Ivana Gojo, Amy E. DeZern, Alexander J. Ambinder, Tania Jain, Gabrielle T. Prince, Lukasz P. Gondek, Theodoros Karantanos, Gabriel Ghiaur, William Brian Dalton, Jonathan Allen Webster
Journal: Blood
Blood (2024) 144 (Supplement 1): 5904.
https://doi.org/10.1182/blood-2024-207608
Published: 2024
Journal Articles

Acute Lymphoblastic Leukemia (ALL) Outcomes after Allogeneic Blood or Marrow Transplantation (alloBMT) with High-Dose Post-Transplantation Cyclophosphamide (PTCy) in the Era of More Effective Pre-Transplant Therapy

Jonathan Allen Webster, Madison C Reed, Hua-Ling Tsai, Philip Imus, B. Douglas Smith, Alexander J. Ambinder, Mark J. Levis, Amy E. DeZern, Gabrielle T. Prince, Javier Bolanos-Meade, Lukasz P. Gondek, Gabriel Ghiaur, William Brian Dalton, Theodoros Karantanos, Suman Paul, Ephraim Joseph Fuchs, Cole Sterling, Lode J. Swinnen, Nina Wagner-Johnston, Richard F. Ambinder, Christian B. Gocke, Syed Abbas Ali, Carol Ann Huff, Leo Luznik, Ravi Varadhan, Richard J. Jones, Ivana Gojo
Journal: Blood
Blood (2024) 144 (Supplement 1): 3551.
https://doi.org/10.1182/blood-2024-212141
Published: 2024
Journal Articles

Outcomes of Patients with TP53 -Mutated Myeloid Neoplasms (TP53-MN) and the Role of Allogenic Blood or Marrow Transplantation (alloBMT)

Sergiu Pasca, Saurav D. Haldar, Alexander J. Ambinder, Jonathan Webster, Tania Jain, William Brian Dalton, Gabrielle T. Prince, Gabriel Ghiaur, Amy E. DeZern, Ivana Gojo, Jonathan Allen Webster, Cory Schulz, Kristin Stokvis, Mark J. Levis, Richard J. Jones, Lukasz P. Gondek
Journal: Blood
Blood (2022) 140 (Supplement 1): 10629–10631.
https://doi.org/10.1182/blood-2022-169148
Published: 2022
Journal Articles

CCRL2 Promotes Cytokine-Regulated Growth of Erythroleukemia Cells

Theodoros Karantanos, Christopher Esteb, Patric Teodorescu, Brandy Perkins, Ilias Christodoulou, Stamatia Vorri, Trivikram Rajkhowa, William Brian Dalton, Gabriel Ghiaur, Richard J. Jones
Journal: Blood
Blood (2022) 140 (Supplement 1): 5866–5867.
https://doi.org/10.1182/blood-2022-159538
Published: 2022
Journal Articles

Allogeneic Blood or Marrow Transplantation (AlloBMT) with High-Dose Post-Transplantation Cyclophosphamide (PTCy) for Acute Lymphoblastic Leukemia (ALL) in Patients Aged ≥ 55: Best Results in B ALL in First Remission (CR1) with Reduced-Intensity Conditioning (RIC)

Jonathan Allen Webster, Madison C. Reed, Hua-Ling Tsai, Alexander J. Ambinder, Tania Jain, Amy E. DeZern, Mark J. Levis, Margaret M. Showel, Gabrielle T. Prince, Christopher S. Hourigan, Javier Bolaños-Meade, Lukasz P. Gondek, Gabriel Ghiaur, William Brian Dalton, Suman Paul, Ephraim J. Fuchs, Christian B. Gocke, Abbas Abbas Ali, Douglas E. Gladstone, Carol Ann Huff, Ivan M. Borrello, Lode J. Swinnen, Nina D. Wagner-Johnston, Richard F. Ambinder, Leo Luznik, Ivana Gojo, B. Douglas Douglas Smith, Ravi Varadhan, Richard J. Jones, Philip H. Imus
Journal: Blood
Blood (2022) 140 (Supplement 1): 4813–4815.
https://doi.org/10.1182/blood-2022-171038
Published: 2022
Journal Articles

Gemtuzumab Ozogamicin for Cytoreduction in Hyperleukocytosis

Matthew Scarlotta, Jonathan Webster, Matthew Newman, Cory Schulz, Kristin Stokvis, Alexander J. Ambinder, Tania Jain, William Brian Dalton, Lukasz P. Gondek, Gabrielle T. Prince, Gabriel Ghiaur, Christopher S. Hourigan, Amy E. DeZern, Ivana Gojo, Jonathan Allen Webster, Mark J. Levis
Journal: Blood
Blood (2022) 140 (Supplement 1): 11747–11748.
https://doi.org/10.1182/blood-2022-160300
Published: 2022
Journal Articles

Nonmyeloablative Allogeneic Transplantation in First Remission for Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia with Post-Transplantation Cyclophosphamide: Outcomes By Receipt of Pre-Transplant Blinatumomab

Jonathan Webster, B. Douglas Smith, Amy E. DeZern, Alexander J. Ambinder, Mark Levis, Margaret M. Showel, Gabrielle T. Prince, Lukasz P. Gondek, Gabriel Ghiaur, William Brian Dalton, Christopher S. Hourigan, Tania Jain, Douglas E Gladstone, Leo Luznik, Philip H. Imus, Javier Bolanos-Meade, Ephraim J. Fuchs, Christian B. Gocke, Abbas Abbas Ali, Carol Ann Huff, Ivan M. Borrello, Lode J. Swinnen, Nina D. Wagner-Johnston, Richard F. Ambinder, Richard J. Jones, Ivana Gojo
Journal: Blood
Blood (2021) 138 (Supplement 1): 1846.
https://doi.org/10.1182/blood-2021-153750
Published: 2021
Journal Articles

Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Post-Transplantation Cyclophosphamide: Assessing the Importance of Conditioning Regimen, Donor Choice, and Tyrosine Kinase Inhibitor Use

Jonathan Webster, MD, Leo Luznik, MD, Hua-Ling Tsai, ScM, Philip H. Imus, MD, Amy E. DeZern, MD, Keith W. Pratz, MD, Mark Levis, MD PhD, Ivana Gojo, MD, Margaret M. Showel, MD, Gabrielle T. Prince, MD, Javier Bolanos-Meade, MD, Lukasz P. Gondek, MDPhD, Gabriel Ghiaur, MD PhD, William Brian Dalton, MD PhD, Tania Jain, MD, Ephraim J. Fuchs, MD MBA, Douglas E Gladstone, MD, Christian B. Gocke, MD PhD, Abbas Abbas Ali, MD, Carol Ann Huff, MD, Ivan M. Borrello, MD, Lode J. Swinnen, MB ChB, Nina D. Wagner-Johnston, Richard F. Ambinder, MD, Richard J. Jones, MD, B. Douglas Smith, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-141294
Published: 2020
Journal Articles

Reduced-Intensity Induction with Dasatinib Vs. Hypercvad + 2 nd Generation TKIs with MRD-Guided Follow-up Therapy Leads to Comparable Rates of MRD-Negative Remission While Reducing Transfusions and Neutropenia in Ph+ ALL

Jonathan Webster, MD, Hua-Ling Tsai, ScM, Eric Gehrie, Tania Jain, MD, Christopher S. Hourigan, MDDPhil, William Brian Dalton, MD PhD, Gabrielle T. Prince, MD, Lukasz P. Gondek, MDPhD, Gabriel Ghiaur, MD PhD, Amy E. DeZern, MD, Margaret M. Showel, MD, Ivana Gojo, MD, Douglas E Gladstone, MD, Philip H. Imus, MD, Javier Bolanos-Meade, MD, Leo Luznik, MD, Ephraim J. Fuchs, MD MBA, Christian B. Gocke, MD PhD, Abbas Abbas Ali, MD, Carol Ann Huff, MD, Ivan M. Borrello, MD, Lode J. Swinnen, MB ChB, Nina D. Wagner-Johnston, Richard F. Ambinder, MD, Richard J. Jones, MD, B. Douglas Smith, MD, Mark Levis, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–44.
https://doi.org/10.1182/blood-2020-141264
Published: 2020
Journal Articles

Coagulopathy, Hypoxemia, and Mortality Outcomes in Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis Treated with Large Volume Leukapheresis

Bryan Hambley, MD, Eric Gehrie, Jonathan Webster, MD, Margaret M. Showel, MD, Lukasz P. Gondek, MD PhD, William Brian Dalton, MD PhD, Gabrielle T. Prince, MD, Douglas E Gladstone, MD, Ivana Gojo, MD, Gabriel Ghiaur, MD PhD, Keith W. Pratz, MD, B. Douglas Smith, MD, Amy E. DeZern, MD, Mark J. Levis, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3841.
https://doi.org/10.1182/blood-2019-123229
Published: 2019